Metabolic dysfunction-associated steatotic liver disease (MASLD) affects men and women differently, yet sex-based differences remain poorly explored. In the week celebrating International Women’s Day, this EASL Studio episode debates the molecular, hormonal, and genetic mechanisms driving these disparities.

Moderator: Saskia van Mil
Faculty: Sara Della Torre and Münevver Demir

Related episode

• S4E9 YI Choice: Gender equality in academics — reducing the gap

All EASL Studio Podcasts are available on EASL Campus.

Click here to see all EASL Video Podcasts on Apple Podcasts.

Tune into this EASL Studio episode to learn about the role of PET imaging in Wilson’s disease. Discover how PET advances understanding, supports treatment decisions, and enhances patient care in managing this rare liver disorder.

Moderator: Debbie Shawcross
Faculty: Aftab Ala, Zoe Mariño and Thomas Sandahl

This EASL Studio is supported by Orphalan and Univar Solutions.
EASL has received no input from Orphalan or Univar Solutions with regards to the content of this programme.

Related episodes

• S4E15: Diagnostic and therapeutic challenges in Wilson’s disease
• S4E7: Genetics in adult liver disease – missed opportunities?

All EASL Studio Podcasts are available on EASL Campus.

Click here to see all EASL Video Podcasts on Apple Podcasts.

Join this EASL Studio episode for a clinical perspective on advancing HCC care. Explore the realities of adjuvant therapies, emerging molecular targets, and strategies for curative conversion. Gain insights into practical innovations shaping the future and translating research into improved patient outcomes.

Moderator: Thomas Berg
Faculty: Tim Greten and Anna Saborowski

This EASL Studio is supported by Bayer.
EASL has received no input from Bayer with regards to the content of this programme.

Related episodes

• EASL Studio S5E13: Basics in decision-making for liver cancer treatment
• EASL Studio from EASL Congress 2023: Highlights of the liver cancer research at EASL Congress 2023
• EASL Studio S4E16: Highlights from the EASL Liver Cancer Summit 2023
• EASL Studio S6E9: Therapy hierarchy in HCC: A new kid on the block

All EASL Studio Podcasts are available on EASL Campus.

Click here to see all EASL Video Podcasts on Apple Podcasts.

Watch this EASL Studio to start navigating your research journey with essential tips on generating ideas, refining hypotheses, and crafting standout abstracts for EASL Congress. Discover how to choose the right journal, prepare a submission-ready manuscript, and boost your career visibility in hepatology.

Moderator: Thomas Marjot
Faculty: Marta Afonso, Emma Andersson and Paolo Angeli

Related episodes

• S4E20 – COST Actions: Opportunities for pan-European collaborations in liver diseases
• S4E14 – EASL-EF CLIF and EU Grants: Exploring novel mechanism and treatment of chronic liver failure
• S4E2 YI Choice – How to build consortia and registries

All EASL Studio Podcasts are available on EASL Campus.

Click here to see all EASL Video Podcasts on Apple Podcasts.

Discover the latest updates from the updated EASL Clinical Practice Guidelines on Hepatocellular Carcinoma (HCC). This episode explores key advancements, their impact on clinical practice, and how they will shape the future of HCC diagnosis, treatment, and management. Join our faculty as they break down the changes and provide practical insights for healthcare professionals.

Moderator: Thomas Berg
Faculty: Peter Galle, Josep Llovet and Lorenza Rimassa

Related episodes

• EASL Studio S6E4: World Cholangiocarcinoma Day: Highlighting Guidelines and Exploring the Horizon Beyond
• EASL Studio S6E9: Therapy Hierarchy in HCC: A New Kid on the Block
• EASL Studio S5E13: Basics in Decision-Making for Liver Cancer Treatment
• EASL Studio Live from EASL Congress 2024: Advances in Systemic Treatments in Liver Cancer

All EASL Studio Podcasts are available on EASL Campus.

Click here to see all EASL Video Podcasts on Apple Podcasts.

Join us for the season premiere of EASL Studio Season 8 as we unpack key insights from the Steatotic Liver Disease (SLD) Summit. Explore the evolving consensus on patient trajectories, advancements in ALD and MetALD treatment pathways, and the latest endpoint discussions. The episode also highlights a holistic approach to diagnosing and managing comorbidities and revisits the standard of care in light of breakthroughs in MASH treatments.

Moderator: Aleksander Krag
Faculty: Cyrielle Caussy, Sven Francque and Brian Lee

This EASL Studio is supported by Madrigal. EASL has received no input from Madrigal with regards to the content of this programme.

Related episodes

• S7E3 – The changing face of Steatotic Liver Disease: Navigating new opportunities and emerging challenges
• EASL Studio at the Congress 2024: SLD nomenclature: Need for refinement?
• EASL Studio at the Congress 2024: MASLD anno 2024: A rapidly changing landscape
• EASL Studio from EASL Congress 2023 – Steatotic liver disease global consensus to change nomenclature

All EASL Studio Podcasts are available on EASL Campus.

Click here to see all EASL Video Podcasts on Apple Podcasts.

This EASL Studio showcases cutting-edge research elucidating the role of the liver in ageing and exploring its role as a regulator of health and longevity. In particular, the liver’s function in modulating systemic ageing, its ability to buffer genetic and metabolic disturbances, and its influence on the progression of age-related diseases is discussed. Last but not least, panelists provides new insights into potential therapeutic strategies aimed at promoting healthy ageing by targeting liver-specific mechanisms.

This episode is related to this study published in July 2024: Inhibition of IL-11 signalling extends mammalian healthspan and lifespan

Faculty: 

• Rui Castro (Moderator)
• Anna Mae Diehl (Faculty)
• Celia Martinez-Jiménez (Faculty)

Related episode

•  EASL Studio S7E8: Sarcopenia: Converting research findings into clinical practice – Are we doing enough?

All EASL Studio Podcasts are available on EASL Campus.

This EASL Studio episode examines the current relevance of Hepatic Encephalopathy (HE) and the roles of hepatologists and interventional radiologists in patient care. The discussion covers technical approaches, patient outcomes, and the expanding indications for TIPS.

Tune in to:

• Learn about the critical roles of hepatologists and radiologists in managing HE.
• Understand technical factors, including TIPS procedures and their application in modern hepatology.
• Explore the use of TIPS for aging patients, those with variceal bleeding, and major surgery candidates.

Faculty

• Virginia Hernández-Gea (Moderator)
• Dominique Thabut (Faculty)
• Dhiraj Tripathi (Faculty)
• Thomas Kröncke (Faculty)

This EASL Studio is supported by an educational grant from Cook Medical. EASL has received no input from Cook Medical with regards to the content of this programme.

Related episodes

• EASL Studio S6E11: Assessment of clinically significant portal hypertension in 2024 – Is it time to say goodbye to invasive measurements?
• EASL Studio S2E14: Elastography – The new non-invasive gold standard in portal hypertension?

All EASL Studio Podcasts are available on EASL Campus.

Sarcopenia, defined by a reduction in muscle mass and strength, significantly increases the risk of hospitalisation and mortality in patients with liver cirrhosis. This EASL Studio episode highlights the importance of incorporating sarcopenia assessment and management into routine clinical practice. Experts discuss the optimal timing for assessment and strategies for implementing effective interventions.

Faculty

• Felicity Williams (Moderator)
• Shelley Keating (Faculty)
• Jennifer Lai (Faculty)
• Jonathan Stine (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

This EASL Studio episode explores how alcohol worsens liver disease in patients with cardiometabolic risks, the stigma affecting diagnosis and care, and the latest therapeutic advances.

Key topics of discussion include:

• Interaction between alcohol and cardiometabolic risks
• Stigma and its impact on patient care
• Identifying at-risk patients with clinical markers
• Emerging therapies and research opportunities

Faculty

• Aleksander Krag (Moderator)
• Fredrik Åberg (Faculty)
• Maru Rinella (Faculty)
• Maja Thiele (Faculty)

This EASL Studio is supported by Boehringer Ingelheim. EASL has received no input from Boehringer Ingelheim with regards to the content of this programme.

Related episodes

• EASL Studio S5E9: Alcohol and the new nomenclature – A game-changer?
• EASL Studio S4E8: The central role of alcohol and food policies on liver health
• EASL Studio S4E3: A 360 approach to beat alcohol-related liver disease
• EASL Studio S3E5: JHEP Live: Stigma and alcohol

All EASL Studio Podcasts are available on EASL Campus.